Sunshine Pharma Records Stable Share Capital in August 2026; Public Float Remains Compliant

Bulletin Express09-03

Sunshine Pharma (Sunshine Lake Pharma Co., Ltd.) has filed its monthly return for the period ended 31 August 2026, confirming there were no changes to either its authorised or issued share capital during the month. The filing was submitted to Hong Kong Exchanges and Clearing Limited on 3 September 2026.

At month-end, authorised share capital stood at 576.66 million shares, split between 321.10 million H shares and 255.55 million domestic shares, each with a par value of RMB 1.00. Both classes recorded zero movement versus July, underscoring a stable capital base.

Issued share capital likewise remained unchanged. The company reported 318.97 million H shares outstanding (excluding 2.13 million treasury shares) and 255.55 million domestic shares, maintaining a total of 576.66 million issued shares. Treasury share levels were flat month-on-month, with no repurchases, cancellations, or transfers recorded.

Sunshine Pharma confirmed full compliance with Hong Kong’s public-float requirements, maintaining at least the mandated 18.53% free-float threshold for its H shares. The company also reported no outstanding share options, warrants, convertibles, or other equity instruments or arrangements that could affect share capital.

The disclosure indicates a steady equity structure with no dilution or capital adjustments during August, reinforcing existing shareholder positions and meeting regulatory obligations on market liquidity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150629402?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-03 17:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150629402","market":"us","top_or_hot":-1,"title":"Sunshine Pharma Records Stable Share Capital in August 2026; Public Float Remains Compliant","media":"Bulletin Express","content":"<p>Sunshine Pharma (Sunshine Lake Pharma Co., Ltd.) has filed its monthly return for the period ended 31 August 2026, confirming there were no changes to either its authorised or issued share capital during the month. The filing was submitted to Hong Kong Exchanges and Clearing Limited on 3 September 2026.</p>\n<p>At month-end, authorised share capital stood at 576.66 million shares, split between 321.10 million H shares and 255.55 million domestic shares, each with a par value of RMB 1.00. Both classes recorded zero movement versus July, underscoring a stable capital base.</p>\n<p>Issued share capital likewise remained unchanged. The company reported 318.97 million H shares outstanding (excluding 2.13 million treasury shares) and 255.55 million domestic shares, maintaining a total of 576.66 million issued shares. Treasury share levels were flat month-on-month, with no repurchases, cancellations, or transfers recorded.</p>\n<p>Sunshine Pharma confirmed full compliance with Hong Kong’s public-float requirements, maintaining at least the mandated 18.53% free-float threshold for its H shares. The company also reported no outstanding share options, warrants, convertibles, or other equity instruments or arrangements that could affect share capital.</p>\n<p>The disclosure indicates a steady equity structure with no dilution or capital adjustments during August, reinforcing existing shareholder positions and meeting regulatory obligations on market liquidity.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sunshine Pharma Records Stable Share Capital in August 2026; Public Float Remains Compliant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSunshine Pharma Records Stable Share Capital in August 2026; Public Float Remains Compliant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-03 17:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sunshine Pharma (Sunshine Lake Pharma Co., Ltd.) has filed its monthly return for the period ended 31 August 2026, confirming there were no changes to either its authorised or issued share capital during the month. The filing was submitted to Hong Kong Exchanges and Clearing Limited on 3 September 2026.</p>\n<p>At month-end, authorised share capital stood at 576.66 million shares, split between 321.10 million H shares and 255.55 million domestic shares, each with a par value of RMB 1.00. Both classes recorded zero movement versus July, underscoring a stable capital base.</p>\n<p>Issued share capital likewise remained unchanged. The company reported 318.97 million H shares outstanding (excluding 2.13 million treasury shares) and 255.55 million domestic shares, maintaining a total of 576.66 million issued shares. Treasury share levels were flat month-on-month, with no repurchases, cancellations, or transfers recorded.</p>\n<p>Sunshine Pharma confirmed full compliance with Hong Kong’s public-float requirements, maintaining at least the mandated 18.53% free-float threshold for its H shares. The company also reported no outstanding share options, warrants, convertibles, or other equity instruments or arrangements that could affect share capital.</p>\n<p>The disclosure indicates a steady equity structure with no dilution or capital adjustments during August, reinforcing existing shareholder positions and meeting regulatory obligations on market liquidity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06887","symbol_name":"东阳光药","start_time":0,"source_url":"","article_id":"1150629402","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150629402","pubTimestamp":1788427578,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sunshine Pharma (Sunshine Lake Pharma Co., Ltd.) has filed its monthly return for the period ended 31 August 2026, confirming there were no changes to either its authorised or issued share capital...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06887":"东阳光药"},"translate_title":"阳光医药2026年8月股本稳定；公众持股量保持合规","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06887":1},"content_text":"Sunshine Pharma (Sunshine Lake Pharma Co., Ltd.) has filed its monthly return for the period ended 31 August 2026, confirming there were no changes to either its authorised or issued share capital during the month. The filing was submitted to Hong Kong Exchanges and Clearing Limited on 3 September 2026.\nAt month-end, authorised share capital stood at 576.66 million shares, split between 321.10 million H shares and 255.55 million domestic shares, each with a par value of RMB 1.00. Both classes recorded zero movement versus July, underscoring a stable capital base.\nIssued share capital likewise remained unchanged. The company reported 318.97 million H shares outstanding (excluding 2.13 million treasury shares) and 255.55 million domestic shares, maintaining a total of 576.66 million issued shares. Treasury share levels were flat month-on-month, with no repurchases, cancellations, or transfers recorded.\nSunshine Pharma confirmed full compliance with Hong Kong’s public-float requirements, maintaining at least the mandated 18.53% free-float threshold for its H shares. The company also reported no outstanding share options, warrants, convertibles, or other equity instruments or arrangements that could affect share capital.\nThe disclosure indicates a steady equity structure with no dilution or capital adjustments during August, reinforcing existing shareholder positions and meeting regulatory obligations on market liquidity.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150629402","isCrawlerRequest":true}